Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Melanoma: HELP
Joan Anton Puig-Butillè
Based on 46 articles published since 2009
(Why 46 articles?)
||||
Expertise Level
The expertise of Joan Anton Puig-Butillè ranks in the
  • Top 0.56%
  • ... of 106,334 published authors worldwide on Melanoma
  • ... from 2009 through 2019
  • ... based on contributions to 46 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Puig-Butillé, J A   ·   Puig-Butillé, Joan-Anton   ·   Puig-Butille, J A   ·   Puig-Butillé, J   ·   Puig-Butillé, Joan Anton   ·   Puig-Butillé, Joan   ·   Puig-Butillé, Joan A   ·   Puig-Butillè, Joan A   ·   Puig-Butille, Joan-Anton   ·   Puig-Butille, Joan A   ·   Puig-Butillè, Joan Anton   ·   Puig-Butille, Joan Anton
Work Locations
Details
Most likely:    Universitat de Barcelona      
2018
  • Department of Dermatology, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Barcelona, Spain. · Department of Biochemistry and Molecular Genetics, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. · Department of Medicine, Division of Genetic Epidemiology, University of Utah School of Medicine, Salt Lake City, UT, USA. · Department of Dermatology, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Barcelona, Spain. · Pubmed 29706638
  • Melanoma Unit, Dermatology Department, Hospital Clínic and IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain. · Melanoma Unit, Biochemistry and Molecular Genetics Department, Hospital Clínic and IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain. Electronic address: · Pubmed 29389327
  • Dermatology Department, Melanoma Unit, Hospital Clínic, IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain. · Dermatology Department, Hospital Alemán, Buenos Aires, Argentina. · Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), ISCIII, Madrid, Spain. · Biochemical and Molecular Genetics Service, Hospital Clínic, IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain. · Medicine Department, Universitat de Barcelona, Barcelona, Spain. · Pubmed 28950052
2017
  • Melanoma Unit, Department of Dermatology, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain. · Department of Dermatology, Memorial Sloan Kettering Cancer Center, New York, New York. · Melanoma Unit, Department of Dermatology, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain; "Centro de Investigación Biomédica en Red en Enfermedades Raras, Instituto de Salud Carlos III", Barcelona, Spain. · "Centro de Investigación Biomédica en Red en Enfermedades Raras, Instituto de Salud Carlos III", Barcelona, Spain; Department of Biochemical and Molecular Genetics, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain. · Melanoma Unit, Department of Dermatology, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain; "Centro de Investigación Biomédica en Red en Enfermedades Raras, Instituto de Salud Carlos III", Barcelona, Spain. Electronic address: · Pubmed 28325390
  • Biochemistry and Molecular Genetics Service, Melanoma Unit, Hospital Clínic, IDIBAPS, CIBERER, Barcelona, Spain. · IDIBELL (Bellvitge Biomedical Research Institute), Centre d' Oncologia Molecular, Barcelona, Spain. · Dermatology Service, IDIBELL-Hospital Universitari de Bellvitge, Barcelona, Spain. · Dermatology Department, Melanoma Unit, Hospital Clínic, IDIBAPS, CIBERER, Barcelona, Spain. · Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), IDIBELL, Barcelona, Spain. · IDIBELL (Bellvitge Biomedical Research Institute), Centre d' Oncologia Molecular, Barcelona, Spain. Electronic address: · Pubmed 28188776
  • Dermatology Department, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Barcelona, Spain. · Department of Dermatology, University Hospital Essen, Essen, Germany & German Cancer Consortium, Heidelberg, Germany. · Biochemical and Molecular Genetics Service, Melanoma Unit, Hospital Clínic de Barcelona, Barcelona, Spain. · Pubmed 28103633
  • Experimental Cancer Genetics, The Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK. · Department of Oncology, Cambridge University Hospitals National Health Service Foundation Trust, Cambridge, UK. · Department of Medical Oncology and Targeted Therapeutics in Solid Tumors Group (IDIBAPS), Hospital Clınic de Barcelona, Barcelona, Spain. · Melanoma Unit, Radiology Service, Hospital Clınic, IDIBAPS, University of Barcelona, Barcelona, Spain. · Melanoma Unit, Department of Dermatology, Hospital Clınic de Barcelona, Barcelona, Spain. · Centre of Biomedical Research on Rare Diseases (CIBERER), ISCIII, Barcelona, Spain. · Melanoma Unit, Department of Dermatology, Hospital Clınic de Barcelona, IDIBAPS, Barcelona University, Barcelona, Spain. · Melanoma Unit, Radiotherapy Oncology, Hospital Clınic, IDIBAPS, Barcelona University, Barcelona, Spain. · Leiden University Medical Centre, Leiden, The Netherlands. · Laboratorio Internacional de Investigacion sobre el Genoma Humano, Universidad Nacional Autonoma de Mexico, Santiago de Queretaro, Mexico. · Biochemistry and Molecular Genetics Department, Melanoma Unit, Hospital Clinic de Barcelona, IDIBAPS, Barcelona, Spain. · Pubmed 28097802
  • Dermatology and Skin Cancer Unit, Arcispedale S. Maria Nuova-IRCCS, Reggio Emilia, Italy. · Dermatology Department, University of Turin, Turin, Italy. · Dermatology Department or Biochemical and Molecular Genetics Service, Melanoma Unit, Hospital Clinic & IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), University of Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red de enfermedades raras (CIBER ER), Instituto de Salud Carlos III, Valencia, Spain. · First Department of Dermatology, Aristotle University, Thessaloniki, Greece. · Pathology Unit, Arcispedale S. Maria Nuova, IRCCS, Reggio Emilia, Italy. · Dermatology Department, Second University of Naples, Naples, Italy. · Pubmed 27790766
2016
  • Hospital Clinic I Provincial de Barcelona, Universitat de Barcelona and Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain2Department of Dermatology, Post-Graduation Program in Pathology, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brazil3Pontifícia Universidade Católica do Rio Grande do Sul, School of Medicine, Porto Alegre, Brazil. · Hospital Clinic I Provincial de Barcelona, Universitat de Barcelona and Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. · Department of Dermatology, Post-Graduation Program in Pathology, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brazil. · Hospital Clinic I Provincial de Barcelona, Universitat de Barcelona and Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain4Centro de Investigación Biomédica en Red en Enfermedades Raras, Barcelona, Spain. · Pubmed 27579522
  • Dermatologia Ente Ospedaliero Cantonale (EOC), Ospedale Regionale Bellinzona e Valli, Bellinzona, Switzerland. , · Melanoma Unit, Hospital Clinic de Barcelona, Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), ISCIII, Barcelona, Spain. · Dermatologia Ente Ospedaliero Cantonale (EOC), Ospedale Regionale Bellinzona e Valli, Bellinzona, Switzerland. · Private Dermatology Practice, Lugano, Switzerland. · Private Dermatology Practice, Bellinzona, Switzerland. · Private Dermatology Practice, Chiasso, Switzerland. · Private Dermatology Practice, Locarno, Switzerland. · Istituto Oncologico della Svizzera Italiana (IOSI), Ospedale Regionale Bellinzona e Valli, Bellinzona, Switzerland. · Biochemistry and Molecular Genetics Service, Hospital Clinic of Barcelona, Spain. · Pubmed 27473757
  • Melanoma Unit, Dermatology Department, Hospital Clínic De Barcelona, IDIBAPS, Universitat De Barcelona, Barcelona, Spain. · Grup D'Immunoreceptors Del Sistema Innat I Adaptatiu, Institut D'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. · Department of Dermatology, University Hospital Essen, Essen, Germany & German Cancer Consortium, Heidelberg, Germany. · Melanoma Unit, Molecular Biology and Genetics Department, Hospital Clínic De Barcelona, Barcelona, Spain. · Centro De Investigación Biomédica En Red En Enfermedades Raras (CIBERER), Valencia, Spain. · Department of Immunology, Hospital Clínic De Barcelona, Barcelona, Spain. · Department of Cell Biology, Immunology and Neurosciences, School of Medicine, University of Barcelona, Barcelona, Spain. · Pubmed 27169428
  • Melanoma Unit, Dermatology Department, Hospital Clínic & IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain. · Centro Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain. · Departament de Medicina, Universitat de Barcelona, Barcelona, Spain. · Consejo Nacional de Ciencia y Tecnología (CONACYT), Ciudad de México, México. · Melanoma Unit, Biochemistry and Molecular Genetics Department, Hospital Clínic & IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain. · Department of Dermatology, Instituto Valenciano de Oncologia, Valencia, Spain. · Universidad Católica de Valencia, Valencia, Spain. · Molecular Biology Unit, Instituto Valenciano de Oncologia, Valencia, Spain. · Division of Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany. · Escola Paulista de Medicina - UNIFESP, São Paulo, Brazil. · International Research Center, AC Camargo Cancer Center, São Paulo, Brazil. · Dermatology Department and Post-Graduation Program of Pathology, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, Brazil. · Servicio de Dermatología, Hospital Dr. Sótero del Río, Santiago de Chile, Chile. · Servicio de Dermatología, Hospital San Juan de Dios, Santiago, Chile. · Pontificia Universidad Católica de Chile, Santiago de Chile, Chile. · Department of Dermatology, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. · Unidad de Lesiones Pigmentadas, Cátedra de Dermatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay. · Instituto de Investigaciones Medicas "A Lanari," Universidad de Buenos Aires, Buenos Aires, Argentina. · Consultorio Dermatológico Drs. Cohen Sabban y Cabo, Buenos Aires, Argentina. · Hospital Especialidades Centro Medico Nacional La Raza, Mexico, DF, Mexico. · Departamento de Ciencias Básicas, Escuela de Medicina Universidad de Monterrey, Monterrey, Mexico. · Departamento de Introducción a la Clínica, Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Mexico. · Servicio de Dermatología, Hospital Universitario "Dr. José Eleuterio González," Monterrey, Mexico. · Pubmed 26681309
  • Melanoma Unit, Dermatology Department, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques d'August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red en Enfermedades Raras, Valencia, Spain3Melanoma Unit, Molecular Biology and Genetics Department, Hospital Clínic de Barcelona, Spain. · Melanoma Unit, Dermatology Department, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques d'August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain2Centro de Investigación Biomédica en Red en Enfermedades Raras, Valencia, Spain. · Department of Dermatology, Hospital Universitari Son Espases, Palma Mallorca, Spain. · Servicio de Dermatología del Hospital Universitario Virgen del Rocío, Sevilla, Spain. · Pubmed 26650189
  • Department of Dermatology, Federal University of São Paulo, São Paulo, Brazil. · Dermatology & Biochemistry and Molecular Genetics Departments, Melanoma Unit, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain. · CIBER de Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain. · Department of Pathology, Federal University of São Paulo, São Paulo, Brazil. · Pathology Service, Melanoma Unit, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain. · University of Barcelona, Barcelona, Spain. · Pubmed 27310877
2015
  • Statistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Institut National de la Santé et de la Recherche Médicale (INSERM), UMR-946, Genetic Variation and Human Diseases Unit, Paris, France. · Institut Universitaire d'Hématologie, Université Paris Diderot, Sorbonne Paris Cité, Paris, France. · Genetic Epidemiology, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Centre for Genetic Origins of Health and Disease, Faculty of Medicine, Dentistry and Health Sciences, The University of Western Australia, Western Australia, Australia. · Departments of Epidemiology and Biostatistics, Key Laboratory of Cancer Prevention and Therapy, Tianjin, National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, P. R. China. · Division of Molecular Genetic Epidemiology, German Cancer Research Center, Im Neuenheimer Feld 580, Heidelberg Germany. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK. · Division of Breast Cancer Research, The Institute of Cancer Research, London, UK. · Department of Dermatology, University of Athens School of Medicine, Andreas Sygros Hospital, Athens, Greece. · Centre for Cancer Biomarkers CCBIO, Department of Clinical Medicine, University of Bergen, Bergen, Norway. · Department of Pathology, Haukeland University Hospital, Bergen, Norway. · Department of Pathology, Molecular Pathology, Oslo University Hospital, Rikshospitalet, Oslo, Norway. · Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, Service de Dermatologie, Université Paris Descartes, Paris, France. · Department of Dermatology, Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv, Israel. · Oncogenetics Unit, Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy. · Laboratory of Genetics of Rare Cancers, Istituto di ricovero e cura a carattere scientifico Azienda Ospedaliera Universitaria (IRCCS AOU) San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. · International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland. · Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Université Paris 13, Equipe de Recherche en Epidémiologie Nutritionnelle (EREN), Centre de Recherche en Epidémiologie et Statistiques, Institut National de la Santé et de la Recherche Médicale (INSERM U1153), Institut National de la Recherche Agronomique (INRA U1125), Conservatoire National des Arts et Métiers, Communauté d'Université Sorbonne Paris Cité, F-93017 Bobigny, France. · Inherited Disease Research Branch, National Human Genome Research Institute, National Institutes of Health, Baltimore, Maryland, USA. · Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands. · Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. · Department of Dermatology, Oslo University Hospital, Rikshospitalet, Oslo, Norway. · Department of Surgical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Department of Surgery, Clinical Sciences, Lund University, Lund, Sweden. · Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA. · Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Medical Genetics, University of Glasgow, Glasgow, UK. · McGill University and Genome Quebec Innovation Centre, Montreal, Canada. · Department of Public Health, University of Glasgow, Glasgow UK. · Centre for Cancer Research, University of Sydney at Westmead, Millennium Institute for Medical Research and Melanoma Institute Australia, Sydney, Australia. · Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway. · Molecular Epidemiology, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Department of Molecular Diagnostics, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Department of Oncology/Pathology, Clinical Sciences, Lund University, Lund; Sweden. · Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden. · Melanoma Unit, Dermatology Department & Biochemistry and Molecular Genetics Departments, Hospital Clinic, Institut de Investigacó Biomèdica August Pi Suñe, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red (CIBER) de Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain. · Department of Dermatology, The Warren Alpert Medical School of Brown University, Rhode Island, USA. · Inflammatory Bowel Diseases, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Department of Gastroenterology and Hepatology, Royal Brisbane & Women's Hospital, Brisbane, Australia. · University of Queensland School of Medicine, Herston Campus, Brisbane, Australia. · Department of Clinical Genetics, Center of Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands. · Cancer Control Group, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Department of Ophthalmology, Flinders University, Adelaide, Australia. · Department of Dermatology, University Hospital Essen, Essen, Germany. · German Consortium Translational Cancer Research (DKTK), Heidelberg, Germany. · Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia. · Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia. · Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK. · Cancer Epidemiology and Services Research, Sydney School of Public Health, The University of Sydney, Australia. · Oncogenomics, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Department of Epidemiology, Richard M. Fairbanks School of Public Health, Indiana University, Indianapolis, Indiana, USA. · Melvin and Bren Simon Cancer Center, Indiana University, Indianapolis, Indiana, USA. · Department of Dermatology, Fachklinik Hornheide, Institute for Tumors of the Skin at the University of Münster, Münster, Germany. · Department of Community and Family Medicine, Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire, USA. · Pubmed 26237428
  • Department of Dermatology, Federal University of São Paulo, São Paulo, Brazil. · Melanoma Unit, Dermatology, Biochemistry and Molecular Genetics Departments, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain. · CIBER de Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain. · Department of Pathology, Federal University of São Paulo, São Paulo, Brazil. · Melanoma Unit, Pathology Service, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain. · University of Barcelona, Barcelona, Spain. · Pubmed 25857817
  • Melanoma Unit, Department of Dermatology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain2Centro de Investigación Biomédica en Red en Enfermedades Raras, Instituto de Salud Carlos III, B. · Centro de Investigación Biomédica en Red en Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain3Department of Biochemical and Molecular Genetics, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barc. · Department of Pathology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain. · Pubmed 25651238
  • Dermatology Department, Melanoma Unit, Hospital Clínic and August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Center for Networked Biomedical Research on Rare Diseases (CIBERER), Carlos III Health Institute (ISCIII), Barcelona, Spain. · Biochemical and Molecular Genetics Service, Hospital Clínic and August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Laboratory of Neurodegenerative Disorders, Department of Clinical and Experimental Neurology, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Hospital Clínic of Barcelona, Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED), Barcelona, Spain. · Medicine Department, University of Barcelona (UB), Barcelona, Spain. · Pubmed 25913870
2014
  • Centro de Investigación Biomédica en Red de Enfermedades Raras ISCIII, Barcelona, Spain; Dermatology Department, Melanoma Unit, Hospital Clinic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. · Centro de Investigación Biomédica en Red de Enfermedades Raras ISCIII, Barcelona, Spain; Biochemical and Molecular Genetics Service, Melanoma Unit, Hospital Clinic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. · Centro de Investigación Biomédica en Red de Enfermedades Raras ISCIII, Barcelona, Spain; Dermatology Department, Melanoma Unit, Hospital Clinic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. Electronic address: · Pubmed 25064638
  • Melanoma Unit, Hospital Clinic and IDIBAPS (Institut d'Investigacions Biomèdiques Agustí Pi i Sunyer), Barcelona, Spain. · Pubmed 24742402
  • Department of Pathology, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain. · Department of Biochemical and Molecular Genetics, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain; Center for Biomedical Network Research on Rare Diseases (CIBERER), the Carlos III Institute of Health (ISCIII), Barcelona, Spain. · Center for Biomedical Network Research on Rare Diseases (CIBERER), the Carlos III Institute of Health (ISCIII), Barcelona, Spain; Department of Dermatology, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain. · Joseph Carreras Institute for Research against Leukemia, Hospital "Germans Trias i Pujol", Autonomous University of Barcelona, Barcelona, Spain. · Department of Pathology, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain. Electronic address: · Pubmed 24374110
  • Department of Pathology, Hospital Clínic, IDIBAPS, University of Barcelona, Spain. · Department of Biochemical and Molecular Genetics, Hospital Clínic, IDIBAPS, University of Barcelona, Spain; Centro Investigación Biomédica en Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain. · Institute of Predictive and Personalized Medicine of Cancer (IMPPC), Badalona, Spain. · Melanoma Unit, Department of Dermatology, Hospital Clínic, IDIBAPS, University of Barcelona, Spain; Centro Investigación Biomédica en Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain. · Institut de Recerca contra la Leucèmia Josep Carreras, Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain. · Department of Pathology, Hospital Clínic, IDIBAPS, University of Barcelona, Spain. Electronic address: · Pubmed 25219713
2013
  • Centro Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Barcelona, Spain; Biochemical and Molecular Genetics Service, Department of Dermatology, Melanoma Unit, Hospital Clinic and IDIBAPS (Institut d'Investigacions Biomèdiques Agustí Pi i Sunyer), Barcelona, Spain. · Pubmed 23647022
2017
  • aMelanoma Unit, Department of Dermatology bMelanoma Unit, Department of Pathology cBiochemical and Molecular Genetics Service, Melanoma Unit, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) dRadiotherapeutic Oncology Service, Melanoma Unit eGeneral Surgery Service, Melanoma Unit fImaging Diagnostic Center, CDI (Radiology and Nuclear Medicine Services), Melanoma Unit, Hospital Clinic gBiomedical Research Center for Rare Diseases, CIBERER. Insituto de Salud Carlos III hMedicine Department, University of Barcelona, Barcelona, Spain. · Pubmed 28296711
2014
  • Melanoma Unit, Dermatology Department, Hospital Clínic of Barcelona, Barcelona, Spain. · Pubmed 24942556
  • Dermatology Department, Melanoma Unit, Hospital Clinic & IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain; National University of Colombia, Bogotá, Colombia. · Pubmed 24749938
2013
  • Melanoma Unit, Dermatology Department, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Universidad de Barcelona, Spain. · Pubmed 22849563
2012
  • Centro Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Biochemical and Molecular Genetics Service, Melanoma Unit, Hospital Clinic, Villarroel, Barcelona, Spain. · Pubmed 23046018
  • Melanoma Unit of the Department of Dermatology, Hospital Clínic of Barcelona, IDIBAPS, Barcelona University, Barcelona, Spain. · Pubmed 22493355
  • Melanoma Unit, Dermatology Department, Hospital Clinic of Barcelona, Institut d'investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. · Pubmed 21683472
2011
  • Melanoma Unit, Department of Dermatology, Hospital Clinic of Barcelona, Institut d'investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. · Pubmed 21281387
  • Department of Dermatology, Melanoma and Dermatopathology Units, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain. · Pubmed 21240454
2009
  • Medical Oncology Department (ICHMO), Institute of Biomedical Investigations August Pi I Sunyer, Hospital Clinic Barcelona, Spain. · Pubmed 19438551
Probable:    Instituto de Salud Carlos III      
2018
  • Department of Dermatology, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Barcelona, Spain. · Department of Biochemistry and Molecular Genetics, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. · Department of Medicine, Division of Genetic Epidemiology, University of Utah School of Medicine, Salt Lake City, UT, USA. · Department of Dermatology, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Barcelona, Spain. · Pubmed 29706638
  • Dermatology Department, Melanoma Unit, Hospital Clínic, IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain. · Dermatology Department, Hospital Alemán, Buenos Aires, Argentina. · Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), ISCIII, Madrid, Spain. · Biochemical and Molecular Genetics Service, Hospital Clínic, IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain. · Medicine Department, Universitat de Barcelona, Barcelona, Spain. · Pubmed 28950052
2017
  • Melanoma Unit, Department of Dermatology, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain. · Department of Dermatology, Memorial Sloan Kettering Cancer Center, New York, New York. · Melanoma Unit, Department of Dermatology, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain; "Centro de Investigación Biomédica en Red en Enfermedades Raras, Instituto de Salud Carlos III", Barcelona, Spain. · "Centro de Investigación Biomédica en Red en Enfermedades Raras, Instituto de Salud Carlos III", Barcelona, Spain; Department of Biochemical and Molecular Genetics, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain. · Melanoma Unit, Department of Dermatology, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain; "Centro de Investigación Biomédica en Red en Enfermedades Raras, Instituto de Salud Carlos III", Barcelona, Spain. Electronic address: · Pubmed 28325390
  • Biochemistry and Molecular Genetics Service, Melanoma Unit, Hospital Clínic, IDIBAPS, CIBERER, Barcelona, Spain. · IDIBELL (Bellvitge Biomedical Research Institute), Centre d' Oncologia Molecular, Barcelona, Spain. · Dermatology Service, IDIBELL-Hospital Universitari de Bellvitge, Barcelona, Spain. · Dermatology Department, Melanoma Unit, Hospital Clínic, IDIBAPS, CIBERER, Barcelona, Spain. · Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), IDIBELL, Barcelona, Spain. · IDIBELL (Bellvitge Biomedical Research Institute), Centre d' Oncologia Molecular, Barcelona, Spain. Electronic address: · Pubmed 28188776
  • Experimental Cancer Genetics, The Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK. · Department of Oncology, Cambridge University Hospitals National Health Service Foundation Trust, Cambridge, UK. · Department of Medical Oncology and Targeted Therapeutics in Solid Tumors Group (IDIBAPS), Hospital Clınic de Barcelona, Barcelona, Spain. · Melanoma Unit, Radiology Service, Hospital Clınic, IDIBAPS, University of Barcelona, Barcelona, Spain. · Melanoma Unit, Department of Dermatology, Hospital Clınic de Barcelona, Barcelona, Spain. · Centre of Biomedical Research on Rare Diseases (CIBERER), ISCIII, Barcelona, Spain. · Melanoma Unit, Department of Dermatology, Hospital Clınic de Barcelona, IDIBAPS, Barcelona University, Barcelona, Spain. · Melanoma Unit, Radiotherapy Oncology, Hospital Clınic, IDIBAPS, Barcelona University, Barcelona, Spain. · Leiden University Medical Centre, Leiden, The Netherlands. · Laboratorio Internacional de Investigacion sobre el Genoma Humano, Universidad Nacional Autonoma de Mexico, Santiago de Queretaro, Mexico. · Biochemistry and Molecular Genetics Department, Melanoma Unit, Hospital Clinic de Barcelona, IDIBAPS, Barcelona, Spain. · Pubmed 28097802
  • Dermatology and Skin Cancer Unit, Arcispedale S. Maria Nuova-IRCCS, Reggio Emilia, Italy. · Dermatology Department, University of Turin, Turin, Italy. · Dermatology Department or Biochemical and Molecular Genetics Service, Melanoma Unit, Hospital Clinic & IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), University of Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red de enfermedades raras (CIBER ER), Instituto de Salud Carlos III, Valencia, Spain. · First Department of Dermatology, Aristotle University, Thessaloniki, Greece. · Pathology Unit, Arcispedale S. Maria Nuova, IRCCS, Reggio Emilia, Italy. · Dermatology Department, Second University of Naples, Naples, Italy. · Pubmed 27790766
2016
  • Dermatologia Ente Ospedaliero Cantonale (EOC), Ospedale Regionale Bellinzona e Valli, Bellinzona, Switzerland. , · Melanoma Unit, Hospital Clinic de Barcelona, Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), ISCIII, Barcelona, Spain. · Dermatologia Ente Ospedaliero Cantonale (EOC), Ospedale Regionale Bellinzona e Valli, Bellinzona, Switzerland. · Private Dermatology Practice, Lugano, Switzerland. · Private Dermatology Practice, Bellinzona, Switzerland. · Private Dermatology Practice, Chiasso, Switzerland. · Private Dermatology Practice, Locarno, Switzerland. · Istituto Oncologico della Svizzera Italiana (IOSI), Ospedale Regionale Bellinzona e Valli, Bellinzona, Switzerland. · Biochemistry and Molecular Genetics Service, Hospital Clinic of Barcelona, Spain. · Pubmed 27473757
  • Melanoma Unit, Dermatology Department, Hospital Clínic De Barcelona, IDIBAPS, Universitat De Barcelona, Barcelona, Spain. · Grup D'Immunoreceptors Del Sistema Innat I Adaptatiu, Institut D'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. · Department of Dermatology, University Hospital Essen, Essen, Germany & German Cancer Consortium, Heidelberg, Germany. · Melanoma Unit, Molecular Biology and Genetics Department, Hospital Clínic De Barcelona, Barcelona, Spain. · Centro De Investigación Biomédica En Red En Enfermedades Raras (CIBERER), Valencia, Spain. · Department of Immunology, Hospital Clínic De Barcelona, Barcelona, Spain. · Department of Cell Biology, Immunology and Neurosciences, School of Medicine, University of Barcelona, Barcelona, Spain. · Pubmed 27169428
  • Melanoma Unit, Dermatology Department, Hospital Clínic & IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain. · Centro Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain. · Departament de Medicina, Universitat de Barcelona, Barcelona, Spain. · Consejo Nacional de Ciencia y Tecnología (CONACYT), Ciudad de México, México. · Melanoma Unit, Biochemistry and Molecular Genetics Department, Hospital Clínic & IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain. · Department of Dermatology, Instituto Valenciano de Oncologia, Valencia, Spain. · Universidad Católica de Valencia, Valencia, Spain. · Molecular Biology Unit, Instituto Valenciano de Oncologia, Valencia, Spain. · Division of Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany. · Escola Paulista de Medicina - UNIFESP, São Paulo, Brazil. · International Research Center, AC Camargo Cancer Center, São Paulo, Brazil. · Dermatology Department and Post-Graduation Program of Pathology, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, Brazil. · Servicio de Dermatología, Hospital Dr. Sótero del Río, Santiago de Chile, Chile. · Servicio de Dermatología, Hospital San Juan de Dios, Santiago, Chile. · Pontificia Universidad Católica de Chile, Santiago de Chile, Chile. · Department of Dermatology, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. · Unidad de Lesiones Pigmentadas, Cátedra de Dermatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay. · Instituto de Investigaciones Medicas "A Lanari," Universidad de Buenos Aires, Buenos Aires, Argentina. · Consultorio Dermatológico Drs. Cohen Sabban y Cabo, Buenos Aires, Argentina. · Hospital Especialidades Centro Medico Nacional La Raza, Mexico, DF, Mexico. · Departamento de Ciencias Básicas, Escuela de Medicina Universidad de Monterrey, Monterrey, Mexico. · Departamento de Introducción a la Clínica, Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Mexico. · Servicio de Dermatología, Hospital Universitario "Dr. José Eleuterio González," Monterrey, Mexico. · Pubmed 26681309
  • Melanoma Unit, Dermatology Department, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques d'August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red en Enfermedades Raras, Valencia, Spain3Melanoma Unit, Molecular Biology and Genetics Department, Hospital Clínic de Barcelona, Spain. · Melanoma Unit, Dermatology Department, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques d'August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain2Centro de Investigación Biomédica en Red en Enfermedades Raras, Valencia, Spain. · Department of Dermatology, Hospital Universitari Son Espases, Palma Mallorca, Spain. · Servicio de Dermatología del Hospital Universitario Virgen del Rocío, Sevilla, Spain. · Pubmed 26650189
  • Department of Dermatology, Federal University of São Paulo, São Paulo, Brazil. · Dermatology & Biochemistry and Molecular Genetics Departments, Melanoma Unit, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain. · CIBER de Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain. · Department of Pathology, Federal University of São Paulo, São Paulo, Brazil. · Pathology Service, Melanoma Unit, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain. · University of Barcelona, Barcelona, Spain. · Pubmed 27310877
  • Dermatology Department, Melanoma Unit, Hospital Clinic and August Pi i Sunyer Biomedical Research Institute. · Center for Networked Biomedical Research on Rare Diseases, Carlos III Health Institute. · Biochemical and Molecular Genetics Service, Hospital Clinic and August Pi i Sunyer Biomedical Research Institute. · Laboratory of Neurodegenerative Disorders, Department of Clinical and Experimental Neurology, August Pi i Sunyer Biomedical Research Institute, Hospital Clinic of Barcelona, Center for Networked Biomedical Research in Neurodegenerative Diseases. · Medicine Department, University of Barcelona, Barcelona, Spain. · Pubmed 26389780
2015
  • Statistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Institut National de la Santé et de la Recherche Médicale (INSERM), UMR-946, Genetic Variation and Human Diseases Unit, Paris, France. · Institut Universitaire d'Hématologie, Université Paris Diderot, Sorbonne Paris Cité, Paris, France. · Genetic Epidemiology, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Centre for Genetic Origins of Health and Disease, Faculty of Medicine, Dentistry and Health Sciences, The University of Western Australia, Western Australia, Australia. · Departments of Epidemiology and Biostatistics, Key Laboratory of Cancer Prevention and Therapy, Tianjin, National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, P. R. China. · Division of Molecular Genetic Epidemiology, German Cancer Research Center, Im Neuenheimer Feld 580, Heidelberg Germany. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK. · Division of Breast Cancer Research, The Institute of Cancer Research, London, UK. · Department of Dermatology, University of Athens School of Medicine, Andreas Sygros Hospital, Athens, Greece. · Centre for Cancer Biomarkers CCBIO, Department of Clinical Medicine, University of Bergen, Bergen, Norway. · Department of Pathology, Haukeland University Hospital, Bergen, Norway. · Department of Pathology, Molecular Pathology, Oslo University Hospital, Rikshospitalet, Oslo, Norway. · Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, Service de Dermatologie, Université Paris Descartes, Paris, France. · Department of Dermatology, Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv, Israel. · Oncogenetics Unit, Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy. · Laboratory of Genetics of Rare Cancers, Istituto di ricovero e cura a carattere scientifico Azienda Ospedaliera Universitaria (IRCCS AOU) San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. · International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland. · Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Université Paris 13, Equipe de Recherche en Epidémiologie Nutritionnelle (EREN), Centre de Recherche en Epidémiologie et Statistiques, Institut National de la Santé et de la Recherche Médicale (INSERM U1153), Institut National de la Recherche Agronomique (INRA U1125), Conservatoire National des Arts et Métiers, Communauté d'Université Sorbonne Paris Cité, F-93017 Bobigny, France. · Inherited Disease Research Branch, National Human Genome Research Institute, National Institutes of Health, Baltimore, Maryland, USA. · Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands. · Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. · Department of Dermatology, Oslo University Hospital, Rikshospitalet, Oslo, Norway. · Department of Surgical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Department of Surgery, Clinical Sciences, Lund University, Lund, Sweden. · Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA. · Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Medical Genetics, University of Glasgow, Glasgow, UK. · McGill University and Genome Quebec Innovation Centre, Montreal, Canada. · Department of Public Health, University of Glasgow, Glasgow UK. · Centre for Cancer Research, University of Sydney at Westmead, Millennium Institute for Medical Research and Melanoma Institute Australia, Sydney, Australia. · Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway. · Molecular Epidemiology, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Department of Molecular Diagnostics, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Department of Oncology/Pathology, Clinical Sciences, Lund University, Lund; Sweden. · Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden. · Melanoma Unit, Dermatology Department & Biochemistry and Molecular Genetics Departments, Hospital Clinic, Institut de Investigacó Biomèdica August Pi Suñe, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red (CIBER) de Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain. · Department of Dermatology, The Warren Alpert Medical School of Brown University, Rhode Island, USA. · Inflammatory Bowel Diseases, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Department of Gastroenterology and Hepatology, Royal Brisbane & Women's Hospital, Brisbane, Australia. · University of Queensland School of Medicine, Herston Campus, Brisbane, Australia. · Department of Clinical Genetics, Center of Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands. · Cancer Control Group, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Department of Ophthalmology, Flinders University, Adelaide, Australia. · Department of Dermatology, University Hospital Essen, Essen, Germany. · German Consortium Translational Cancer Research (DKTK), Heidelberg, Germany. · Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia. · Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia. · Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK. · Cancer Epidemiology and Services Research, Sydney School of Public Health, The University of Sydney, Australia. · Oncogenomics, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Department of Epidemiology, Richard M. Fairbanks School of Public Health, Indiana University, Indianapolis, Indiana, USA. · Melvin and Bren Simon Cancer Center, Indiana University, Indianapolis, Indiana, USA. · Department of Dermatology, Fachklinik Hornheide, Institute for Tumors of the Skin at the University of Münster, Münster, Germany. · Department of Community and Family Medicine, Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire, USA. · Pubmed 26237428
  • Department of Dermatology, Federal University of São Paulo, São Paulo, Brazil. · Melanoma Unit, Dermatology, Biochemistry and Molecular Genetics Departments, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain. · CIBER de Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain. · Department of Pathology, Federal University of São Paulo, São Paulo, Brazil. · Melanoma Unit, Pathology Service, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain. · University of Barcelona, Barcelona, Spain. · Pubmed 25857817
  • Melanoma Unit, Department of Dermatology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain2Centro de Investigación Biomédica en Red en Enfermedades Raras, Instituto de Salud Carlos III, B. · Centro de Investigación Biomédica en Red en Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain3Department of Biochemical and Molecular Genetics, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barc. · Department of Pathology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain. · Pubmed 25651238
  • Dermatology Department, Melanoma Unit, Hospital Clínic and August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Center for Networked Biomedical Research on Rare Diseases (CIBERER), Carlos III Health Institute (ISCIII), Barcelona, Spain. · Biochemical and Molecular Genetics Service, Hospital Clínic and August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Laboratory of Neurodegenerative Disorders, Department of Clinical and Experimental Neurology, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Hospital Clínic of Barcelona, Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED), Barcelona, Spain. · Medicine Department, University of Barcelona (UB), Barcelona, Spain. · Pubmed 25913870
2014
  • Department of Dermatology,University Hospital Essen, West German Cancer Center, University Duisburg-Essen, Essen and the German Cancer Consortium (KGG, BS, EL, TS, IM, MS, AS, UH, LZ, DS), Germany · Department of Pathology and Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY (RM) · CIBER Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain (JAPB, MP, CC, CB, JM, SP) · Department of Dermatology, Hospital Clinic Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain (CC, JM, SP) · Biochemistry and Molecular Genetics Department, Hospital Clinic Barcelona, IDIBAPS, Barcelona, Spain (CB) · Integriertes Forschungs- und Behandlungszentrum (IFB) Sepsis und Sepsisfolgen Center for Sepsis Control and Care (CSCC) University Hospital Jena, Jena, Germany (AS). · Pubmed 25217772
  • Centro de Investigación Biomédica en Red de Enfermedades Raras ISCIII, Barcelona, Spain; Dermatology Department, Melanoma Unit, Hospital Clinic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. · Centro de Investigación Biomédica en Red de Enfermedades Raras ISCIII, Barcelona, Spain; Biochemical and Molecular Genetics Service, Melanoma Unit, Hospital Clinic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. · Centro de Investigación Biomédica en Red de Enfermedades Raras ISCIII, Barcelona, Spain; Dermatology Department, Melanoma Unit, Hospital Clinic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. Electronic address: · Pubmed 25064638
  • Department of Pathology, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain. · Department of Biochemical and Molecular Genetics, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain; Center for Biomedical Network Research on Rare Diseases (CIBERER), the Carlos III Institute of Health (ISCIII), Barcelona, Spain. · Center for Biomedical Network Research on Rare Diseases (CIBERER), the Carlos III Institute of Health (ISCIII), Barcelona, Spain; Department of Dermatology, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain. · Joseph Carreras Institute for Research against Leukemia, Hospital "Germans Trias i Pujol", Autonomous University of Barcelona, Barcelona, Spain. · Department of Pathology, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain. Electronic address: · Pubmed 24374110
  • Department of Pathology, Hospital Clínic, IDIBAPS, University of Barcelona, Spain. · Department of Biochemical and Molecular Genetics, Hospital Clínic, IDIBAPS, University of Barcelona, Spain; Centro Investigación Biomédica en Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain. · Institute of Predictive and Personalized Medicine of Cancer (IMPPC), Badalona, Spain. · Melanoma Unit, Department of Dermatology, Hospital Clínic, IDIBAPS, University of Barcelona, Spain; Centro Investigación Biomédica en Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain. · Institut de Recerca contra la Leucèmia Josep Carreras, Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain. · Department of Pathology, Hospital Clínic, IDIBAPS, University of Barcelona, Spain. Electronic address: · Pubmed 25219713
2013
  • Centro Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Barcelona, Spain; Biochemical and Molecular Genetics Service, Department of Dermatology, Melanoma Unit, Hospital Clinic and IDIBAPS (Institut d'Investigacions Biomèdiques Agustí Pi i Sunyer), Barcelona, Spain. · Pubmed 23647022
  • Centro Investigación Biomédica en Enfermedades Raras, ISCIII, Barcelona, Spain. · Pubmed 23362874
2017
  • aMelanoma Unit, Department of Dermatology bMelanoma Unit, Department of Pathology cBiochemical and Molecular Genetics Service, Melanoma Unit, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) dRadiotherapeutic Oncology Service, Melanoma Unit eGeneral Surgery Service, Melanoma Unit fImaging Diagnostic Center, CDI (Radiology and Nuclear Medicine Services), Melanoma Unit, Hospital Clinic gBiomedical Research Center for Rare Diseases, CIBERER. Insituto de Salud Carlos III hMedicine Department, University of Barcelona, Barcelona, Spain. · Pubmed 28296711
2015
  • Dermatology, Department, Melanoma Unit, Hospital Clínic and August Pi i Sunyer Biomedical Research Institute (IDIBAPS); Center for Biomedical Network Research on Rare Diseases (CIBERER), Carlos III Health Institute (ISCIII). · Pubmed 25631192
2012
  • Centro Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Biochemical and Molecular Genetics Service, Melanoma Unit, Hospital Clinic, Villarroel, Barcelona, Spain. · Pubmed 23046018
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 46 total) written by Joan Anton Puig-Butillè about Melanoma:

  • Genome-wide linkage analysis in Spanish melanoma-prone families identifies a new familial melanoma susceptibility locus at 11q. 2018
  • Clinical, Epidemiological, and Molecular Heterogeneity in Acral Melanoma. 2018
  • Melanocortin 1 receptor (MC1R) polymorphisms' influence on size and dermoscopic features of nevi. 2018
  • Patterns of distribution of giant congenital melanocytic nevi (GCMN): The 6B rule. 2017
  • Prognostic role of the histological subtype of melanoma on the hands and feet in Caucasians. 2017
  • AURKA Overexpression Is Driven by FOXM1 and MAPK/ERK Activation in Melanoma Cells Harboring BRAF or NRAS Mutations: Impact on Melanoma Prognosis and Therapy. 2017
  • IRF4 rs12203592 functional variant and melanoma survival. 2017
  • Genomic analysis and clinical management of adolescent cutaneous melanoma. 2017
  • Association between dermoscopic and reflectance confocal microscopy features of cutaneous melanoma with BRAF mutational status. 2017
  • Association Between Confocal Morphologic Classification and Clinical Phenotypes of Multiple Primary and Familial Melanomas. 2016
Show List of Full Article Records
Google Searches

Learn more about Joan Anton Puig-Butillè using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Universitat de Barcelona
Instituto de Salud Carlos III
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Universitat de Barcelona
2018
  • Department of Dermatology, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Barcelona, Spain. · Department of Biochemistry and Molecular Genetics, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. · Department of Medicine, Division of Genetic Epidemiology, University of Utah School of Medicine, Salt Lake City, UT, USA. · Department of Dermatology, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Barcelona, Spain. · Pubmed 29706638
  • Melanoma Unit, Dermatology Department, Hospital Clínic and IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain. · Melanoma Unit, Biochemistry and Molecular Genetics Department, Hospital Clínic and IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain. Electronic address: · Pubmed 29389327
  • Dermatology Department, Melanoma Unit, Hospital Clínic, IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain. · Dermatology Department, Hospital Alemán, Buenos Aires, Argentina. · Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), ISCIII, Madrid, Spain. · Biochemical and Molecular Genetics Service, Hospital Clínic, IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain. · Medicine Department, Universitat de Barcelona, Barcelona, Spain. · Pubmed 28950052
2017
  • Melanoma Unit, Department of Dermatology, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain. · Department of Dermatology, Memorial Sloan Kettering Cancer Center, New York, New York. · Melanoma Unit, Department of Dermatology, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain; "Centro de Investigación Biomédica en Red en Enfermedades Raras, Instituto de Salud Carlos III", Barcelona, Spain. · "Centro de Investigación Biomédica en Red en Enfermedades Raras, Instituto de Salud Carlos III", Barcelona, Spain; Department of Biochemical and Molecular Genetics, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain. · Melanoma Unit, Department of Dermatology, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain; "Centro de Investigación Biomédica en Red en Enfermedades Raras, Instituto de Salud Carlos III", Barcelona, Spain. Electronic address: · Pubmed 28325390
  • Biochemistry and Molecular Genetics Service, Melanoma Unit, Hospital Clínic, IDIBAPS, CIBERER, Barcelona, Spain. · IDIBELL (Bellvitge Biomedical Research Institute), Centre d' Oncologia Molecular, Barcelona, Spain. · Dermatology Service, IDIBELL-Hospital Universitari de Bellvitge, Barcelona, Spain. · Dermatology Department, Melanoma Unit, Hospital Clínic, IDIBAPS, CIBERER, Barcelona, Spain. · Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), IDIBELL, Barcelona, Spain. · IDIBELL (Bellvitge Biomedical Research Institute), Centre d' Oncologia Molecular, Barcelona, Spain. Electronic address: · Pubmed 28188776
  • Dermatology Department, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Barcelona, Spain. · Department of Dermatology, University Hospital Essen, Essen, Germany & German Cancer Consortium, Heidelberg, Germany. · Biochemical and Molecular Genetics Service, Melanoma Unit, Hospital Clínic de Barcelona, Barcelona, Spain. · Pubmed 28103633
  • Experimental Cancer Genetics, The Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK. · Department of Oncology, Cambridge University Hospitals National Health Service Foundation Trust, Cambridge, UK. · Department of Medical Oncology and Targeted Therapeutics in Solid Tumors Group (IDIBAPS), Hospital Clınic de Barcelona, Barcelona, Spain. · Melanoma Unit, Radiology Service, Hospital Clınic, IDIBAPS, University of Barcelona, Barcelona, Spain. · Melanoma Unit, Department of Dermatology, Hospital Clınic de Barcelona, Barcelona, Spain. · Centre of Biomedical Research on Rare Diseases (CIBERER), ISCIII, Barcelona, Spain. · Melanoma Unit, Department of Dermatology, Hospital Clınic de Barcelona, IDIBAPS, Barcelona University, Barcelona, Spain. · Melanoma Unit, Radiotherapy Oncology, Hospital Clınic, IDIBAPS, Barcelona University, Barcelona, Spain. · Leiden University Medical Centre, Leiden, The Netherlands. · Laboratorio Internacional de Investigacion sobre el Genoma Humano, Universidad Nacional Autonoma de Mexico, Santiago de Queretaro, Mexico. · Biochemistry and Molecular Genetics Department, Melanoma Unit, Hospital Clinic de Barcelona, IDIBAPS, Barcelona, Spain. · Pubmed 28097802
  • Dermatology and Skin Cancer Unit, Arcispedale S. Maria Nuova-IRCCS, Reggio Emilia, Italy. · Dermatology Department, University of Turin, Turin, Italy. · Dermatology Department or Biochemical and Molecular Genetics Service, Melanoma Unit, Hospital Clinic & IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), University of Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red de enfermedades raras (CIBER ER), Instituto de Salud Carlos III, Valencia, Spain. · First Department of Dermatology, Aristotle University, Thessaloniki, Greece. · Pathology Unit, Arcispedale S. Maria Nuova, IRCCS, Reggio Emilia, Italy. · Dermatology Department, Second University of Naples, Naples, Italy. · Pubmed 27790766
2016
  • Hospital Clinic I Provincial de Barcelona, Universitat de Barcelona and Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain2Department of Dermatology, Post-Graduation Program in Pathology, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brazil3Pontifícia Universidade Católica do Rio Grande do Sul, School of Medicine, Porto Alegre, Brazil. · Hospital Clinic I Provincial de Barcelona, Universitat de Barcelona and Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. · Department of Dermatology, Post-Graduation Program in Pathology, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brazil. · Hospital Clinic I Provincial de Barcelona, Universitat de Barcelona and Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain4Centro de Investigación Biomédica en Red en Enfermedades Raras, Barcelona, Spain. · Pubmed 27579522
  • Dermatologia Ente Ospedaliero Cantonale (EOC), Ospedale Regionale Bellinzona e Valli, Bellinzona, Switzerland. , · Melanoma Unit, Hospital Clinic de Barcelona, Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), ISCIII, Barcelona, Spain. · Dermatologia Ente Ospedaliero Cantonale (EOC), Ospedale Regionale Bellinzona e Valli, Bellinzona, Switzerland. · Private Dermatology Practice, Lugano, Switzerland. · Private Dermatology Practice, Bellinzona, Switzerland. · Private Dermatology Practice, Chiasso, Switzerland. · Private Dermatology Practice, Locarno, Switzerland. · Istituto Oncologico della Svizzera Italiana (IOSI), Ospedale Regionale Bellinzona e Valli, Bellinzona, Switzerland. · Biochemistry and Molecular Genetics Service, Hospital Clinic of Barcelona, Spain. · Pubmed 27473757
  • Melanoma Unit, Dermatology Department, Hospital Clínic De Barcelona, IDIBAPS, Universitat De Barcelona, Barcelona, Spain. · Grup D'Immunoreceptors Del Sistema Innat I Adaptatiu, Institut D'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. · Department of Dermatology, University Hospital Essen, Essen, Germany & German Cancer Consortium, Heidelberg, Germany. · Melanoma Unit, Molecular Biology and Genetics Department, Hospital Clínic De Barcelona, Barcelona, Spain. · Centro De Investigación Biomédica En Red En Enfermedades Raras (CIBERER), Valencia, Spain. · Department of Immunology, Hospital Clínic De Barcelona, Barcelona, Spain. · Department of Cell Biology, Immunology and Neurosciences, School of Medicine, University of Barcelona, Barcelona, Spain. · Pubmed 27169428
  • Melanoma Unit, Dermatology Department, Hospital Clínic & IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain. · Centro Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain. · Departament de Medicina, Universitat de Barcelona, Barcelona, Spain. · Consejo Nacional de Ciencia y Tecnología (CONACYT), Ciudad de México, México. · Melanoma Unit, Biochemistry and Molecular Genetics Department, Hospital Clínic & IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain. · Department of Dermatology, Instituto Valenciano de Oncologia, Valencia, Spain. · Universidad Católica de Valencia, Valencia, Spain. · Molecular Biology Unit, Instituto Valenciano de Oncologia, Valencia, Spain. · Division of Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany. · Escola Paulista de Medicina - UNIFESP, São Paulo, Brazil. · International Research Center, AC Camargo Cancer Center, São Paulo, Brazil. · Dermatology Department and Post-Graduation Program of Pathology, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, Brazil. · Servicio de Dermatología, Hospital Dr. Sótero del Río, Santiago de Chile, Chile. · Servicio de Dermatología, Hospital San Juan de Dios, Santiago, Chile. · Pontificia Universidad Católica de Chile, Santiago de Chile, Chile. · Department of Dermatology, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. · Unidad de Lesiones Pigmentadas, Cátedra de Dermatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay. · Instituto de Investigaciones Medicas "A Lanari," Universidad de Buenos Aires, Buenos Aires, Argentina. · Consultorio Dermatológico Drs. Cohen Sabban y Cabo, Buenos Aires, Argentina. · Hospital Especialidades Centro Medico Nacional La Raza, Mexico, DF, Mexico. · Departamento de Ciencias Básicas, Escuela de Medicina Universidad de Monterrey, Monterrey, Mexico. · Departamento de Introducción a la Clínica, Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Mexico. · Servicio de Dermatología, Hospital Universitario "Dr. José Eleuterio González," Monterrey, Mexico. · Pubmed 26681309
  • Melanoma Unit, Dermatology Department, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques d'August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red en Enfermedades Raras, Valencia, Spain3Melanoma Unit, Molecular Biology and Genetics Department, Hospital Clínic de Barcelona, Spain. · Melanoma Unit, Dermatology Department, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques d'August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain2Centro de Investigación Biomédica en Red en Enfermedades Raras, Valencia, Spain. · Department of Dermatology, Hospital Universitari Son Espases, Palma Mallorca, Spain. · Servicio de Dermatología del Hospital Universitario Virgen del Rocío, Sevilla, Spain. · Pubmed 26650189
  • Department of Dermatology, Federal University of São Paulo, São Paulo, Brazil. · Dermatology & Biochemistry and Molecular Genetics Departments, Melanoma Unit, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain. · CIBER de Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain. · Department of Pathology, Federal University of São Paulo, São Paulo, Brazil. · Pathology Service, Melanoma Unit, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain. · University of Barcelona, Barcelona, Spain. · Pubmed 27310877
2015
  • Statistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Institut National de la Santé et de la Recherche Médicale (INSERM), UMR-946, Genetic Variation and Human Diseases Unit, Paris, France. · Institut Universitaire d'Hématologie, Université Paris Diderot, Sorbonne Paris Cité, Paris, France. · Genetic Epidemiology, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Centre for Genetic Origins of Health and Disease, Faculty of Medicine, Dentistry and Health Sciences, The University of Western Australia, Western Australia, Australia. · Departments of Epidemiology and Biostatistics, Key Laboratory of Cancer Prevention and Therapy, Tianjin, National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, P. R. China. · Division of Molecular Genetic Epidemiology, German Cancer Research Center, Im Neuenheimer Feld 580, Heidelberg Germany. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK. · Division of Breast Cancer Research, The Institute of Cancer Research, London, UK. · Department of Dermatology, University of Athens School of Medicine, Andreas Sygros Hospital, Athens, Greece. · Centre for Cancer Biomarkers CCBIO, Department of Clinical Medicine, University of Bergen, Bergen, Norway. · Department of Pathology, Haukeland University Hospital, Bergen, Norway. · Department of Pathology, Molecular Pathology, Oslo University Hospital, Rikshospitalet, Oslo, Norway. · Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, Service de Dermatologie, Université Paris Descartes, Paris, France. · Department of Dermatology, Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv, Israel. · Oncogenetics Unit, Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy. · Laboratory of Genetics of Rare Cancers, Istituto di ricovero e cura a carattere scientifico Azienda Ospedaliera Universitaria (IRCCS AOU) San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. · International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland. · Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Université Paris 13, Equipe de Recherche en Epidémiologie Nutritionnelle (EREN), Centre de Recherche en Epidémiologie et Statistiques, Institut National de la Santé et de la Recherche Médicale (INSERM U1153), Institut National de la Recherche Agronomique (INRA U1125), Conservatoire National des Arts et Métiers, Communauté d'Université Sorbonne Paris Cité, F-93017 Bobigny, France. · Inherited Disease Research Branch, National Human Genome Research Institute, National Institutes of Health, Baltimore, Maryland, USA. · Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands. · Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. · Department of Dermatology, Oslo University Hospital, Rikshospitalet, Oslo, Norway. · Department of Surgical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Department of Surgery, Clinical Sciences, Lund University, Lund, Sweden. · Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA. · Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Medical Genetics, University of Glasgow, Glasgow, UK. · McGill University and Genome Quebec Innovation Centre, Montreal, Canada. · Department of Public Health, University of Glasgow, Glasgow UK. · Centre for Cancer Research, University of Sydney at Westmead, Millennium Institute for Medical Research and Melanoma Institute Australia, Sydney, Australia. · Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway. · Molecular Epidemiology, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Department of Molecular Diagnostics, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Department of Oncology/Pathology, Clinical Sciences, Lund University, Lund; Sweden. · Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden. · Melanoma Unit, Dermatology Department & Biochemistry and Molecular Genetics Departments, Hospital Clinic, Institut de Investigacó Biomèdica August Pi Suñe, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red (CIBER) de Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain. · Department of Dermatology, The Warren Alpert Medical School of Brown University, Rhode Island, USA. · Inflammatory Bowel Diseases, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Department of Gastroenterology and Hepatology, Royal Brisbane & Women's Hospital, Brisbane, Australia. · University of Queensland School of Medicine, Herston Campus, Brisbane, Australia. · Department of Clinical Genetics, Center of Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands. · Cancer Control Group, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Department of Ophthalmology, Flinders University, Adelaide, Australia. · Department of Dermatology, University Hospital Essen, Essen, Germany. · German Consortium Translational Cancer Research (DKTK), Heidelberg, Germany. · Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia. · Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia. · Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK. · Cancer Epidemiology and Services Research, Sydney School of Public Health, The University of Sydney, Australia. · Oncogenomics, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Department of Epidemiology, Richard M. Fairbanks School of Public Health, Indiana University, Indianapolis, Indiana, USA. · Melvin and Bren Simon Cancer Center, Indiana University, Indianapolis, Indiana, USA. · Department of Dermatology, Fachklinik Hornheide, Institute for Tumors of the Skin at the University of Münster, Münster, Germany. · Department of Community and Family Medicine, Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire, USA. · Pubmed 26237428
  • Department of Dermatology, Federal University of São Paulo, São Paulo, Brazil. · Melanoma Unit, Dermatology, Biochemistry and Molecular Genetics Departments, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain. · CIBER de Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain. · Department of Pathology, Federal University of São Paulo, São Paulo, Brazil. · Melanoma Unit, Pathology Service, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain. · University of Barcelona, Barcelona, Spain. · Pubmed 25857817
  • Melanoma Unit, Department of Dermatology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain2Centro de Investigación Biomédica en Red en Enfermedades Raras, Instituto de Salud Carlos III, B. · Centro de Investigación Biomédica en Red en Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain3Department of Biochemical and Molecular Genetics, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barc. · Department of Pathology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain. · Pubmed 25651238
  • Dermatology Department, Melanoma Unit, Hospital Clínic and August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Center for Networked Biomedical Research on Rare Diseases (CIBERER), Carlos III Health Institute (ISCIII), Barcelona, Spain. · Biochemical and Molecular Genetics Service, Hospital Clínic and August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Laboratory of Neurodegenerative Disorders, Department of Clinical and Experimental Neurology, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Hospital Clínic of Barcelona, Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED), Barcelona, Spain. · Medicine Department, University of Barcelona (UB), Barcelona, Spain. · Pubmed 25913870
2014
  • Centro de Investigación Biomédica en Red de Enfermedades Raras ISCIII, Barcelona, Spain; Dermatology Department, Melanoma Unit, Hospital Clinic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. · Centro de Investigación Biomédica en Red de Enfermedades Raras ISCIII, Barcelona, Spain; Biochemical and Molecular Genetics Service, Melanoma Unit, Hospital Clinic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. · Centro de Investigación Biomédica en Red de Enfermedades Raras ISCIII, Barcelona, Spain; Dermatology Department, Melanoma Unit, Hospital Clinic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. Electronic address: · Pubmed 25064638
  • Melanoma Unit, Hospital Clinic and IDIBAPS (Institut d'Investigacions Biomèdiques Agustí Pi i Sunyer), Barcelona, Spain. · Pubmed 24742402
  • Department of Pathology, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain. · Department of Biochemical and Molecular Genetics, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain; Center for Biomedical Network Research on Rare Diseases (CIBERER), the Carlos III Institute of Health (ISCIII), Barcelona, Spain. · Center for Biomedical Network Research on Rare Diseases (CIBERER), the Carlos III Institute of Health (ISCIII), Barcelona, Spain; Department of Dermatology, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain. · Joseph Carreras Institute for Research against Leukemia, Hospital "Germans Trias i Pujol", Autonomous University of Barcelona, Barcelona, Spain. · Department of Pathology, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain. Electronic address: · Pubmed 24374110
  • Department of Pathology, Hospital Clínic, IDIBAPS, University of Barcelona, Spain. · Department of Biochemical and Molecular Genetics, Hospital Clínic, IDIBAPS, University of Barcelona, Spain; Centro Investigación Biomédica en Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain. · Institute of Predictive and Personalized Medicine of Cancer (IMPPC), Badalona, Spain. · Melanoma Unit, Department of Dermatology, Hospital Clínic, IDIBAPS, University of Barcelona, Spain; Centro Investigación Biomédica en Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain. · Institut de Recerca contra la Leucèmia Josep Carreras, Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain. · Department of Pathology, Hospital Clínic, IDIBAPS, University of Barcelona, Spain. Electronic address: · Pubmed 25219713
2013
  • Centro Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Barcelona, Spain; Biochemical and Molecular Genetics Service, Department of Dermatology, Melanoma Unit, Hospital Clinic and IDIBAPS (Institut d'Investigacions Biomèdiques Agustí Pi i Sunyer), Barcelona, Spain. · Pubmed 23647022
2017
  • aMelanoma Unit, Department of Dermatology bMelanoma Unit, Department of Pathology cBiochemical and Molecular Genetics Service, Melanoma Unit, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) dRadiotherapeutic Oncology Service, Melanoma Unit eGeneral Surgery Service, Melanoma Unit fImaging Diagnostic Center, CDI (Radiology and Nuclear Medicine Services), Melanoma Unit, Hospital Clinic gBiomedical Research Center for Rare Diseases, CIBERER. Insituto de Salud Carlos III hMedicine Department, University of Barcelona, Barcelona, Spain. · Pubmed 28296711
2014
  • Melanoma Unit, Dermatology Department, Hospital Clínic of Barcelona, Barcelona, Spain. · Pubmed 24942556
  • Dermatology Department, Melanoma Unit, Hospital Clinic & IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain; National University of Colombia, Bogotá, Colombia. · Pubmed 24749938
2013
  • Melanoma Unit, Dermatology Department, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Universidad de Barcelona, Spain. · Pubmed 22849563
2012
  • Centro Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Biochemical and Molecular Genetics Service, Melanoma Unit, Hospital Clinic, Villarroel, Barcelona, Spain. · Pubmed 23046018
  • Melanoma Unit of the Department of Dermatology, Hospital Clínic of Barcelona, IDIBAPS, Barcelona University, Barcelona, Spain. · Pubmed 22493355
  • Melanoma Unit, Dermatology Department, Hospital Clinic of Barcelona, Institut d'investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. · Pubmed 21683472
2011
  • Melanoma Unit, Department of Dermatology, Hospital Clinic of Barcelona, Institut d'investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. · Pubmed 21281387
  • Department of Dermatology, Melanoma and Dermatopathology Units, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain. · Pubmed 21240454
2009
  • Medical Oncology Department (ICHMO), Institute of Biomedical Investigations August Pi I Sunyer, Hospital Clinic Barcelona, Spain. · Pubmed 19438551
Instituto de Salud Carlos III
2018
  • Department of Dermatology, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Barcelona, Spain. · Department of Biochemistry and Molecular Genetics, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. · Department of Medicine, Division of Genetic Epidemiology, University of Utah School of Medicine, Salt Lake City, UT, USA. · Department of Dermatology, Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Barcelona, Spain. · Pubmed 29706638
  • Dermatology Department, Melanoma Unit, Hospital Clínic, IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain. · Dermatology Department, Hospital Alemán, Buenos Aires, Argentina. · Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), ISCIII, Madrid, Spain. · Biochemical and Molecular Genetics Service, Hospital Clínic, IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain. · Medicine Department, Universitat de Barcelona, Barcelona, Spain. · Pubmed 28950052
2017
  • Melanoma Unit, Department of Dermatology, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain. · Department of Dermatology, Memorial Sloan Kettering Cancer Center, New York, New York. · Melanoma Unit, Department of Dermatology, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain; "Centro de Investigación Biomédica en Red en Enfermedades Raras, Instituto de Salud Carlos III", Barcelona, Spain. · "Centro de Investigación Biomédica en Red en Enfermedades Raras, Instituto de Salud Carlos III", Barcelona, Spain; Department of Biochemical and Molecular Genetics, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain. · Melanoma Unit, Department of Dermatology, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain; "Centro de Investigación Biomédica en Red en Enfermedades Raras, Instituto de Salud Carlos III", Barcelona, Spain. Electronic address: · Pubmed 28325390
  • Biochemistry and Molecular Genetics Service, Melanoma Unit, Hospital Clínic, IDIBAPS, CIBERER, Barcelona, Spain. · IDIBELL (Bellvitge Biomedical Research Institute), Centre d' Oncologia Molecular, Barcelona, Spain. · Dermatology Service, IDIBELL-Hospital Universitari de Bellvitge, Barcelona, Spain. · Dermatology Department, Melanoma Unit, Hospital Clínic, IDIBAPS, CIBERER, Barcelona, Spain. · Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), IDIBELL, Barcelona, Spain. · IDIBELL (Bellvitge Biomedical Research Institute), Centre d' Oncologia Molecular, Barcelona, Spain. Electronic address: · Pubmed 28188776
  • Experimental Cancer Genetics, The Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK. · Department of Oncology, Cambridge University Hospitals National Health Service Foundation Trust, Cambridge, UK. · Department of Medical Oncology and Targeted Therapeutics in Solid Tumors Group (IDIBAPS), Hospital Clınic de Barcelona, Barcelona, Spain. · Melanoma Unit, Radiology Service, Hospital Clınic, IDIBAPS, University of Barcelona, Barcelona, Spain. · Melanoma Unit, Department of Dermatology, Hospital Clınic de Barcelona, Barcelona, Spain. · Centre of Biomedical Research on Rare Diseases (CIBERER), ISCIII, Barcelona, Spain. · Melanoma Unit, Department of Dermatology, Hospital Clınic de Barcelona, IDIBAPS, Barcelona University, Barcelona, Spain. · Melanoma Unit, Radiotherapy Oncology, Hospital Clınic, IDIBAPS, Barcelona University, Barcelona, Spain. · Leiden University Medical Centre, Leiden, The Netherlands. · Laboratorio Internacional de Investigacion sobre el Genoma Humano, Universidad Nacional Autonoma de Mexico, Santiago de Queretaro, Mexico. · Biochemistry and Molecular Genetics Department, Melanoma Unit, Hospital Clinic de Barcelona, IDIBAPS, Barcelona, Spain. · Pubmed 28097802
  • Dermatology and Skin Cancer Unit, Arcispedale S. Maria Nuova-IRCCS, Reggio Emilia, Italy. · Dermatology Department, University of Turin, Turin, Italy. · Dermatology Department or Biochemical and Molecular Genetics Service, Melanoma Unit, Hospital Clinic & IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), University of Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red de enfermedades raras (CIBER ER), Instituto de Salud Carlos III, Valencia, Spain. · First Department of Dermatology, Aristotle University, Thessaloniki, Greece. · Pathology Unit, Arcispedale S. Maria Nuova, IRCCS, Reggio Emilia, Italy. · Dermatology Department, Second University of Naples, Naples, Italy. · Pubmed 27790766
2016
  • Dermatologia Ente Ospedaliero Cantonale (EOC), Ospedale Regionale Bellinzona e Valli, Bellinzona, Switzerland. , · Melanoma Unit, Hospital Clinic de Barcelona, Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), ISCIII, Barcelona, Spain. · Dermatologia Ente Ospedaliero Cantonale (EOC), Ospedale Regionale Bellinzona e Valli, Bellinzona, Switzerland. · Private Dermatology Practice, Lugano, Switzerland. · Private Dermatology Practice, Bellinzona, Switzerland. · Private Dermatology Practice, Chiasso, Switzerland. · Private Dermatology Practice, Locarno, Switzerland. · Istituto Oncologico della Svizzera Italiana (IOSI), Ospedale Regionale Bellinzona e Valli, Bellinzona, Switzerland. · Biochemistry and Molecular Genetics Service, Hospital Clinic of Barcelona, Spain. · Pubmed 27473757
  • Melanoma Unit, Dermatology Department, Hospital Clínic De Barcelona, IDIBAPS, Universitat De Barcelona, Barcelona, Spain. · Grup D'Immunoreceptors Del Sistema Innat I Adaptatiu, Institut D'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. · Department of Dermatology, University Hospital Essen, Essen, Germany & German Cancer Consortium, Heidelberg, Germany. · Melanoma Unit, Molecular Biology and Genetics Department, Hospital Clínic De Barcelona, Barcelona, Spain. · Centro De Investigación Biomédica En Red En Enfermedades Raras (CIBERER), Valencia, Spain. · Department of Immunology, Hospital Clínic De Barcelona, Barcelona, Spain. · Department of Cell Biology, Immunology and Neurosciences, School of Medicine, University of Barcelona, Barcelona, Spain. · Pubmed 27169428
  • Melanoma Unit, Dermatology Department, Hospital Clínic & IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain. · Centro Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain. · Departament de Medicina, Universitat de Barcelona, Barcelona, Spain. · Consejo Nacional de Ciencia y Tecnología (CONACYT), Ciudad de México, México. · Melanoma Unit, Biochemistry and Molecular Genetics Department, Hospital Clínic & IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain. · Department of Dermatology, Instituto Valenciano de Oncologia, Valencia, Spain. · Universidad Católica de Valencia, Valencia, Spain. · Molecular Biology Unit, Instituto Valenciano de Oncologia, Valencia, Spain. · Division of Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany. · Escola Paulista de Medicina - UNIFESP, São Paulo, Brazil. · International Research Center, AC Camargo Cancer Center, São Paulo, Brazil. · Dermatology Department and Post-Graduation Program of Pathology, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, Brazil. · Servicio de Dermatología, Hospital Dr. Sótero del Río, Santiago de Chile, Chile. · Servicio de Dermatología, Hospital San Juan de Dios, Santiago, Chile. · Pontificia Universidad Católica de Chile, Santiago de Chile, Chile. · Department of Dermatology, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. · Unidad de Lesiones Pigmentadas, Cátedra de Dermatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay. · Instituto de Investigaciones Medicas "A Lanari," Universidad de Buenos Aires, Buenos Aires, Argentina. · Consultorio Dermatológico Drs. Cohen Sabban y Cabo, Buenos Aires, Argentina. · Hospital Especialidades Centro Medico Nacional La Raza, Mexico, DF, Mexico. · Departamento de Ciencias Básicas, Escuela de Medicina Universidad de Monterrey, Monterrey, Mexico. · Departamento de Introducción a la Clínica, Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Mexico. · Servicio de Dermatología, Hospital Universitario "Dr. José Eleuterio González," Monterrey, Mexico. · Pubmed 26681309
  • Melanoma Unit, Dermatology Department, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques d'August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red en Enfermedades Raras, Valencia, Spain3Melanoma Unit, Molecular Biology and Genetics Department, Hospital Clínic de Barcelona, Spain. · Melanoma Unit, Dermatology Department, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques d'August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain2Centro de Investigación Biomédica en Red en Enfermedades Raras, Valencia, Spain. · Department of Dermatology, Hospital Universitari Son Espases, Palma Mallorca, Spain. · Servicio de Dermatología del Hospital Universitario Virgen del Rocío, Sevilla, Spain. · Pubmed 26650189
  • Department of Dermatology, Federal University of São Paulo, São Paulo, Brazil. · Dermatology & Biochemistry and Molecular Genetics Departments, Melanoma Unit, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain. · CIBER de Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain. · Department of Pathology, Federal University of São Paulo, São Paulo, Brazil. · Pathology Service, Melanoma Unit, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain. · University of Barcelona, Barcelona, Spain. · Pubmed 27310877
  • Dermatology Department, Melanoma Unit, Hospital Clinic and August Pi i Sunyer Biomedical Research Institute. · Center for Networked Biomedical Research on Rare Diseases, Carlos III Health Institute. · Biochemical and Molecular Genetics Service, Hospital Clinic and August Pi i Sunyer Biomedical Research Institute. · Laboratory of Neurodegenerative Disorders, Department of Clinical and Experimental Neurology, August Pi i Sunyer Biomedical Research Institute, Hospital Clinic of Barcelona, Center for Networked Biomedical Research in Neurodegenerative Diseases. · Medicine Department, University of Barcelona, Barcelona, Spain. · Pubmed 26389780
2015
  • Statistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Institut National de la Santé et de la Recherche Médicale (INSERM), UMR-946, Genetic Variation and Human Diseases Unit, Paris, France. · Institut Universitaire d'Hématologie, Université Paris Diderot, Sorbonne Paris Cité, Paris, France. · Genetic Epidemiology, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Centre for Genetic Origins of Health and Disease, Faculty of Medicine, Dentistry and Health Sciences, The University of Western Australia, Western Australia, Australia. · Departments of Epidemiology and Biostatistics, Key Laboratory of Cancer Prevention and Therapy, Tianjin, National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, P. R. China. · Division of Molecular Genetic Epidemiology, German Cancer Research Center, Im Neuenheimer Feld 580, Heidelberg Germany. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK. · Division of Breast Cancer Research, The Institute of Cancer Research, London, UK. · Department of Dermatology, University of Athens School of Medicine, Andreas Sygros Hospital, Athens, Greece. · Centre for Cancer Biomarkers CCBIO, Department of Clinical Medicine, University of Bergen, Bergen, Norway. · Department of Pathology, Haukeland University Hospital, Bergen, Norway. · Department of Pathology, Molecular Pathology, Oslo University Hospital, Rikshospitalet, Oslo, Norway. · Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, Service de Dermatologie, Université Paris Descartes, Paris, France. · Department of Dermatology, Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv, Israel. · Oncogenetics Unit, Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy. · Laboratory of Genetics of Rare Cancers, Istituto di ricovero e cura a carattere scientifico Azienda Ospedaliera Universitaria (IRCCS AOU) San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. · International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland. · Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Université Paris 13, Equipe de Recherche en Epidémiologie Nutritionnelle (EREN), Centre de Recherche en Epidémiologie et Statistiques, Institut National de la Santé et de la Recherche Médicale (INSERM U1153), Institut National de la Recherche Agronomique (INRA U1125), Conservatoire National des Arts et Métiers, Communauté d'Université Sorbonne Paris Cité, F-93017 Bobigny, France. · Inherited Disease Research Branch, National Human Genome Research Institute, National Institutes of Health, Baltimore, Maryland, USA. · Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands. · Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. · Department of Dermatology, Oslo University Hospital, Rikshospitalet, Oslo, Norway. · Department of Surgical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Department of Surgery, Clinical Sciences, Lund University, Lund, Sweden. · Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA. · Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Medical Genetics, University of Glasgow, Glasgow, UK. · McGill University and Genome Quebec Innovation Centre, Montreal, Canada. · Department of Public Health, University of Glasgow, Glasgow UK. · Centre for Cancer Research, University of Sydney at Westmead, Millennium Institute for Medical Research and Melanoma Institute Australia, Sydney, Australia. · Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway. · Molecular Epidemiology, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Department of Molecular Diagnostics, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Department of Oncology/Pathology, Clinical Sciences, Lund University, Lund; Sweden. · Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden. · Melanoma Unit, Dermatology Department & Biochemistry and Molecular Genetics Departments, Hospital Clinic, Institut de Investigacó Biomèdica August Pi Suñe, Universitat de Barcelona, Barcelona, Spain. · Centro de Investigación Biomédica en Red (CIBER) de Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain. · Department of Dermatology, The Warren Alpert Medical School of Brown University, Rhode Island, USA. · Inflammatory Bowel Diseases, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Department of Gastroenterology and Hepatology, Royal Brisbane & Women's Hospital, Brisbane, Australia. · University of Queensland School of Medicine, Herston Campus, Brisbane, Australia. · Department of Clinical Genetics, Center of Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands. · Cancer Control Group, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Department of Ophthalmology, Flinders University, Adelaide, Australia. · Department of Dermatology, University Hospital Essen, Essen, Germany. · German Consortium Translational Cancer Research (DKTK), Heidelberg, Germany. · Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia. · Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia. · Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK. · Cancer Epidemiology and Services Research, Sydney School of Public Health, The University of Sydney, Australia. · Oncogenomics, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Department of Epidemiology, Richard M. Fairbanks School of Public Health, Indiana University, Indianapolis, Indiana, USA. · Melvin and Bren Simon Cancer Center, Indiana University, Indianapolis, Indiana, USA. · Department of Dermatology, Fachklinik Hornheide, Institute for Tumors of the Skin at the University of Münster, Münster, Germany. · Department of Community and Family Medicine, Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire, USA. · Pubmed 26237428
  • Department of Dermatology, Federal University of São Paulo, São Paulo, Brazil. · Melanoma Unit, Dermatology, Biochemistry and Molecular Genetics Departments, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain. · CIBER de Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain. · Department of Pathology, Federal University of São Paulo, São Paulo, Brazil. · Melanoma Unit, Pathology Service, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain. · University of Barcelona, Barcelona, Spain. · Pubmed 25857817
  • Melanoma Unit, Department of Dermatology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain2Centro de Investigación Biomédica en Red en Enfermedades Raras, Instituto de Salud Carlos III, B. · Centro de Investigación Biomédica en Red en Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain3Department of Biochemical and Molecular Genetics, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barc. · Department of Pathology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain. · Pubmed 25651238
  • Dermatology Department, Melanoma Unit, Hospital Clínic and August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Center for Networked Biomedical Research on Rare Diseases (CIBERER), Carlos III Health Institute (ISCIII), Barcelona, Spain. · Biochemical and Molecular Genetics Service, Hospital Clínic and August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Laboratory of Neurodegenerative Disorders, Department of Clinical and Experimental Neurology, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Hospital Clínic of Barcelona, Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED), Barcelona, Spain. · Medicine Department, University of Barcelona (UB), Barcelona, Spain. · Pubmed 25913870
2014
  • Department of Dermatology,University Hospital Essen, West German Cancer Center, University Duisburg-Essen, Essen and the German Cancer Consortium (KGG, BS, EL, TS, IM, MS, AS, UH, LZ, DS), Germany · Department of Pathology and Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY (RM) · CIBER Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain (JAPB, MP, CC, CB, JM, SP) · Department of Dermatology, Hospital Clinic Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain (CC, JM, SP) · Biochemistry and Molecular Genetics Department, Hospital Clinic Barcelona, IDIBAPS, Barcelona, Spain (CB) · Integriertes Forschungs- und Behandlungszentrum (IFB) Sepsis und Sepsisfolgen Center for Sepsis Control and Care (CSCC) University Hospital Jena, Jena, Germany (AS). · Pubmed 25217772
  • Centro de Investigación Biomédica en Red de Enfermedades Raras ISCIII, Barcelona, Spain; Dermatology Department, Melanoma Unit, Hospital Clinic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. · Centro de Investigación Biomédica en Red de Enfermedades Raras ISCIII, Barcelona, Spain; Biochemical and Molecular Genetics Service, Melanoma Unit, Hospital Clinic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. · Centro de Investigación Biomédica en Red de Enfermedades Raras ISCIII, Barcelona, Spain; Dermatology Department, Melanoma Unit, Hospital Clinic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. Electronic address: · Pubmed 25064638
  • Department of Pathology, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain. · Department of Biochemical and Molecular Genetics, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain; Center for Biomedical Network Research on Rare Diseases (CIBERER), the Carlos III Institute of Health (ISCIII), Barcelona, Spain. · Center for Biomedical Network Research on Rare Diseases (CIBERER), the Carlos III Institute of Health (ISCIII), Barcelona, Spain; Department of Dermatology, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain. · Joseph Carreras Institute for Research against Leukemia, Hospital "Germans Trias i Pujol", Autonomous University of Barcelona, Barcelona, Spain. · Department of Pathology, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain. Electronic address: · Pubmed 24374110
  • Department of Pathology, Hospital Clínic, IDIBAPS, University of Barcelona, Spain. · Department of Biochemical and Molecular Genetics, Hospital Clínic, IDIBAPS, University of Barcelona, Spain; Centro Investigación Biomédica en Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain. · Institute of Predictive and Personalized Medicine of Cancer (IMPPC), Badalona, Spain. · Melanoma Unit, Department of Dermatology, Hospital Clínic, IDIBAPS, University of Barcelona, Spain; Centro Investigación Biomédica en Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain. · Institut de Recerca contra la Leucèmia Josep Carreras, Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain. · Department of Pathology, Hospital Clínic, IDIBAPS, University of Barcelona, Spain. Electronic address: · Pubmed 25219713
2013
  • Centro Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Barcelona, Spain; Biochemical and Molecular Genetics Service, Department of Dermatology, Melanoma Unit, Hospital Clinic and IDIBAPS (Institut d'Investigacions Biomèdiques Agustí Pi i Sunyer), Barcelona, Spain. · Pubmed 23647022
  • Centro Investigación Biomédica en Enfermedades Raras, ISCIII, Barcelona, Spain. · Pubmed 23362874
2017
  • aMelanoma Unit, Department of Dermatology bMelanoma Unit, Department of Pathology cBiochemical and Molecular Genetics Service, Melanoma Unit, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) dRadiotherapeutic Oncology Service, Melanoma Unit eGeneral Surgery Service, Melanoma Unit fImaging Diagnostic Center, CDI (Radiology and Nuclear Medicine Services), Melanoma Unit, Hospital Clinic gBiomedical Research Center for Rare Diseases, CIBERER. Insituto de Salud Carlos III hMedicine Department, University of Barcelona, Barcelona, Spain. · Pubmed 28296711
2015
  • Dermatology, Department, Melanoma Unit, Hospital Clínic and August Pi i Sunyer Biomedical Research Institute (IDIBAPS); Center for Biomedical Network Research on Rare Diseases (CIBERER), Carlos III Health Institute (ISCIII). · Pubmed 25631192
2012
  • Centro Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Biochemical and Molecular Genetics Service, Melanoma Unit, Hospital Clinic, Villarroel, Barcelona, Spain. · Pubmed 23046018
Unspecified
2016
  • Dermatology Department, Melanoma Unit, Hospital Clinic and August Pi i Sunyer Biomedical Research Institute. · Center for Networked Biomedical Research on Rare Diseases, Carlos III Health Institute. · Biochemical and Molecular Genetics Service, Hospital Clinic and August Pi i Sunyer Biomedical Research Institute. · Laboratory of Neurodegenerative Disorders, Department of Clinical and Experimental Neurology, August Pi i Sunyer Biomedical Research Institute, Hospital Clinic of Barcelona, Center for Networked Biomedical Research in Neurodegenerative Diseases. · Medicine Department, University of Barcelona, Barcelona, Spain. · Pubmed 26389780
2014
  • Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, Leeds Cancer Research UK Centre, University of Leeds, Leeds, UK (MMI, DTB, JCT, MHa, JRM, JANB, JHB) · Oncogenomics (NKH), Genetic Epidemiology (NGM), Inflammatory Bowel Diseases Laboratory (GLRS), Cancer Control Group (DCW), Statistical Genetics (SM, MHL), and Molecular Epidemiology (GWM), QIMR Berghofer Medical Research Institute, Brisbane, Australia · INSERM, UMR-946, Genetic Variation and Human Diseases Unit, Paris, France (MB, FD) · Université Paris Diderot, Sorbonne Paris Cité, Institut Universitaire d'Hématologie, Paris, France (MB, FD) · Cancer Epidemiology and Services Research, Sydney School of Public Health, University of Sydney, Australia (AEC) · Department of Oncology, University of Cambridge, Cambridge, UK (AMD, PDPP) · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX (JEL) · Centre for Genetic Origins of Health and Disease, Faculty of Medicine, Dentistry and Health Sciences, University of Western Australia, Crawley, Australia (EKM, SVW) · Centre for Cancer Biomarkers CCBIO (LAA) and Gade Laboratory for Pathology (AM), Department of Clinical Medicine, University of Bergen, Bergen, Norway · Department of Pathology, Haukeland University Hospital, Bergen, Norway (LAA) · Department of Pathology, Molecular Pathology (PAA) and Department of Dermatology (PH), Oslo University Hospital, Rikshospitalet, Oslo, Norway · Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, Service de Dermatologie, Université Paris Descartes, Paris, France (MFA) · Department of Dermatology (EA) and Oncogenics Unit (EA, EF), Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv, Israel (EA) · Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy (GBS, EFPG) · Laboratory of Genetics of Rare Hereditary Cancers, San Martino-IST Research Hospital, Genoa, Italy (GBS, EFPG) · Division of Cancer Epidemiology and Gene · Pubmed 25231748
18 Other Locations Show
Yearly article counts 03686963302
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.